OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
ONPH
Oncology Pharma Inc.
Oncology Pharma Inc.
One Sansome Street
Suite 3500
San Francisco, CA 94104
Not available
None
4225 Executive Square, Suite 600
La Jolla, CA 92037
Research, development, and commercialization of therapeutic drugs and medical devices designed for treatment of many types of cancers.
1. Licensing agreements allowing for revenue generation by the Company from the sale of drugs or medical devices in exchange for Company funding of research and development efforts of various licensors. In addition to upfront payments, the Company is usually required to pay the Licensor of the intellectual property rights a royalty during the term of the agreement which normally extends for much of the period of exclusivity of patent rights for the intellectual property. 2. Leased office facilities at the Company address of record. The lease includes various services and well as occupancy rights.
